$2.05 Billion Infertility Treatment Market by Procedure, Product, Patient Type, End User - Global Forecasts to 2022 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Infertility Treatment Market by Procedure, Product, Patient Type, End User - Global Forecasts to 2022" report to their offering.

The global infertility treatment market is expected to reach USD 2.05 billion by 2022 from USD 1.24 billion in 2017, at a CAGR of 10.6% from 2017 to 2022

Growth in this market is primarily driven by factors such as the continuous decline in fertility rates; increasing public-private investments, funds, and grants; growing public awareness about infertility and the available treatment options; the rising number of fertility clinics worldwide; and technological advancements in infertility treatment devices are the majors drivers for the growth of the infertility treatment market. On the other hand, the high procedural cost of assisted reproductive techniques in developed markets and unsupportive government regulations for certain infertility treatment options are expected to limit market growth to a certain extent.

The infertility treatment market is fairly competitive, with a large number of global and local manufacturers of infertility treatment products. The Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) were the top three players in the infertility treatment market in 2016. Product launches, approvals, and product enhancements; agreements, partnerships, and collaborations; and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the infertility treatment market during 2014-2017.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Infertility Treatment Market, By Procedure

7 Infertility Treatment Market, By Product

8 Infertility Treatment Market, By Patient Type

9 Infertility Treatment Market, By End User

10 Infertility Treatment Market, By Region

11 Competitive Landscape

12 Company Profiles

  • Surelife Pte Ltd. (SingAPOre)
  • Biogenics Inc. (U.S.)
  • Cook Group Incorporated (U.S.)
  • Esco Micro Pte. Ltd. (Singapore)
  • Genea Limited (Australia)
  • Hamilton Throne Ltd. (U.S.)
  • Ihmedical A/S (Denmark)
  • Invo Bioscience (U.S.)
  • Irvine Scientific (U.S.)
  • Ivftech APS (Denmark)
  • Kitazato (Japan)
  • Labotect GmbH (Germany)
  • Lifeglobal Group LLC (U.S.)
  • Medgyn Products Inc. (U.S.)
  • Microtech Ivf S.R.O. (Czech Republic)
  • Nikon Instruments Inc. (U.S.)
  • Ri.Mos (Italy)
  • Rinovum Women's Health Company (U.S.)
  • Rocket Medical PLC (U.K.)
  • Somatex Medical Technologies GmbH (Germany)
  • The Baker Company Inc. (U.S.)
  • The Cooper Companies Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Vitrolife AB (Sweden)
  • Zander Scientific Inc. (U.S.)

For more information about this report visit http://www.researchandmarkets.com/research/v9gr7c/infertility

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health, Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Women's Health, Sexual and Reproductive Health Drugs